Antisense bcl-2 treatment increases programmed cell death in non-small cell lung cancer cell lines.
Koty PP, Zhang H, Levitt ML. Antisense bcl-2 treatment increases programmed cell death in non-small cell lung cancer cell lines. Lung Cancer. 1999 Feb; 23(2):115-27.